TXNIP and diabetes mellitus: Lam et al. generated TXNIP knockout and TXNIP overexpression mouse models and observed that the impairment in Ach-mediated vasorelaxation and the increase in nucleotide-binding domain-like receptor 3 (NLRP3) levels induced by diabetes were attenuated in the TXNIP knockout model.